Our aim in this study was to evaluate how secretoneurin levels changed in the group with ischemic stroke, assess the diagnostic performance of secretoneurin in the group that underwent mechanical thrombectomy, and investigate its correlation with disease severity and its prognostic value. Here, SCG2 is linked to ischemic stroke.